1. Home
  2. ALLK vs INHD Comparison

ALLK vs INHD Comparison

Compare ALLK & INHD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALLK
  • INHD
  • Stock Information
  • Founded
  • ALLK 2012
  • INHD 2019
  • Country
  • ALLK United States
  • INHD United States
  • Employees
  • ALLK N/A
  • INHD N/A
  • Industry
  • ALLK Biotechnology: Pharmaceutical Preparations
  • INHD
  • Sector
  • ALLK Health Care
  • INHD
  • Exchange
  • ALLK Nasdaq
  • INHD Nasdaq
  • Market Cap
  • ALLK 23.0M
  • INHD 19.8M
  • IPO Year
  • ALLK 2018
  • INHD 2023
  • Fundamental
  • Price
  • ALLK $0.33
  • INHD $7.27
  • Analyst Decision
  • ALLK Hold
  • INHD
  • Analyst Count
  • ALLK 3
  • INHD 0
  • Target Price
  • ALLK $2.00
  • INHD N/A
  • AVG Volume (30 Days)
  • ALLK 2.2M
  • INHD 39.1K
  • Earning Date
  • ALLK 05-08-2025
  • INHD 05-12-2025
  • Dividend Yield
  • ALLK N/A
  • INHD N/A
  • EPS Growth
  • ALLK N/A
  • INHD N/A
  • EPS
  • ALLK N/A
  • INHD N/A
  • Revenue
  • ALLK N/A
  • INHD $916,878.00
  • Revenue This Year
  • ALLK N/A
  • INHD N/A
  • Revenue Next Year
  • ALLK N/A
  • INHD N/A
  • P/E Ratio
  • ALLK N/A
  • INHD N/A
  • Revenue Growth
  • ALLK N/A
  • INHD 39.48
  • 52 Week Low
  • ALLK $0.22
  • INHD $3.00
  • 52 Week High
  • ALLK $1.56
  • INHD $10.23
  • Technical
  • Relative Strength Index (RSI)
  • ALLK 60.40
  • INHD 67.11
  • Support Level
  • ALLK $0.31
  • INHD $5.22
  • Resistance Level
  • ALLK $0.33
  • INHD $10.23
  • Average True Range (ATR)
  • ALLK 0.00
  • INHD 0.64
  • MACD
  • ALLK 0.00
  • INHD 0.24
  • Stochastic Oscillator
  • ALLK 78.50
  • INHD 47.47

About ALLK Allakos Inc.

Allakos Inc is a clinical-stage company developing therapeutic antibodies that selectively target immunomodulatory receptors present on the surface of immune effector cells involved in allergic, inflammatory, and proliferative diseases. The company's program, AK006 targets Siglec-6, an inhibitory receptor expressed selectively on mast cells. Binding of AK006 to Siglec-6 is designed to activate the native inhibitory function of the receptor which in turn reduces mast cell activation. Its portfolio consists of antibodies that target receptors, particularly Siglec-6, Siglec-8 and other anti-Siglec antibodies, including some antibodies in preclinical development.

About INHD Inno Holdings Inc.

Inno Holdings Inc is a building technology company with a mission to transform the construction industry with its proprietary cold-formed steel-framing technology and other innovations. It is a manufacturer of cold-formed-steel members and prefabricated homes. It offers a full range of services required to transform raw materials into precise steel framing products and prefabricated homes. The company sells these finished products either to businesses or directly to customers. The finished products and cold-formed-steel members are used in a variety of building types, including residential, commercial, industrial and infrastructure.

Share on Social Networks: